Outbound Sales for HealthTech at Public Company
A step-by-step playbook for implementing outbound sales at a Public Company-stage HealthTech company. This guide covers everything from initial setup and team requirements to execution, measurement, and optimization — tailored specifically for HealthTech companies with publicly accountable marketing budget tied to quarterly targets and large, specialized teams with institutional processes. Includes specific KPIs, recommended tools, common pitfalls to avoid, and expert insights from Ehsan Jahandarpour.
Timeline: 1-2 weeks
Prerequisites
- ✓ Established product with proven product-market fit
- ✓ Analytics infrastructure capturing key user events
- ✓ HIPAA, FDA, and healthcare-specific regulations require specialized compliance infrastructure — ensure compliance before scaling
- ✓ CRM and email sequencing tools configured
- ✓ At least 5 closed deals to validate ICP assumptions
Step-by-Step Guide
Define your ideal customer profile
Build a detailed ICP based on company size, industry, tech stack, funding stage, and pain points. The more specific, the higher your response rates. For HealthTech companies at the Public Company stage, this step is particularly important given predictable growth and shareholder value creation.
Pro tip: Analyze your last 20 closed-won deals — what do those companies have in common? In the HealthTech context, also consider: HIPAA compliance complexity.
Build targeted prospect lists
Use data tools to build lists of companies and decision-makers that match your ICP. Enrich with intent signals and technographic data. For HealthTech companies at the Public Company stage, this step is particularly important given predictable growth and shareholder value creation.
Pro tip: Prioritize companies showing buying signals: hiring for relevant roles, using competitor tools, or raising funding. In the HealthTech context, also consider: slow adoption by medical professionals.
Write personalized outreach sequences
Create multi-touch sequences across email, LinkedIn, and phone. Each message should reference something specific about the prospect company. For HealthTech companies at the Public Company stage, this step is particularly important given predictable growth and shareholder value creation.
Pro tip: First email should be under 100 words. Lead with their problem, not your product. In the HealthTech context, also consider: long procurement cycles.
Set up sales tech stack
Implement a CRM, email sequencer, dialer, and LinkedIn automation tool. Connect everything for unified tracking and reporting. For HealthTech companies at the Public Company stage, this step is particularly important given predictable growth and shareholder value creation.
Pro tip: Start with HubSpot or Salesforce + Apollo or Outreach. Do not over-tool early. In the HealthTech context, also consider: clinical validation requirements.
Execute and iterate on outreach
Launch sequences, track open/reply rates, A/B test subject lines and CTAs. Aim for 30-50% open rates and 5-10% reply rates. For HealthTech companies at the Public Company stage, this step is particularly important given predictable growth and shareholder value creation.
Pro tip: Send outbound Tuesday through Thursday, 8-10am in the prospect timezone for best response rates. In the HealthTech context, also consider: HIPAA compliance complexity.
Build the handoff to AEs
Create a clear process for SDRs to qualify and hand off meetings to account executives. Define qualification criteria and handoff protocols. For HealthTech companies at the Public Company stage, this step is particularly important given predictable growth and shareholder value creation.
Pro tip: Record every discovery call and review weekly as a team — pattern recognition improves qualification. In the HealthTech context, also consider: slow adoption by medical professionals.
Expected Outcomes
- ✓ 15-25 qualified meetings booked per SDR per month targeting HealthTech
- ✓ Email reply rate above 8% for personalized outbound sequences
- ✓ Outbound-sourced pipeline contributing 30-50% of total pipeline
- ✓ Average deal size 2x higher for outbound HealthTech deals vs inbound
KPIs to Track
- ● Meetings booked per SDR
- ● Email reply rate
- ● Pipeline generated
- ● SDR-sourced revenue
Common Mistakes to Avoid
Ehsan's Growth Commentary
HealthTech outbound sales is the slowest-converting channel in B2B because hospital and health system procurement is designed to be slow (protecting patient safety through careful evaluation). A HealthTech company's outbound sequence might take 12-18 months from first touchpoint to signed contract. The healthtech outbound approach: target clinical champions (physicians, department heads) rather than procurement. Clinical champions who see value in your product will drive the internal procurement process — a single enthusiastic physician can accelerate procurement by 6-12 months. The outbound message should speak clinical language, not sales language. "Our AI reduced false positive rates by 23% in a peer-reviewed study at [hospital]" resonates with clinicians. "Our platform improves workflow efficiency" does not. Lead with clinical evidence, cite published studies, and offer a clinical pilot (not a "demo") — terminology matters in healthcare because it signals whether you understand the clinical environment.
The first email should be about them, not you. Lead with a specific observation about their company or role. In HealthTech, multi-threaded outreach (contacting 3+ people at the same account) increases response rates by 50%. Follow up at least 5 times. 80% of deals require 5+ touches, but 90% of salespeople give up after 2.
Ehsan Jahandarpour
AI Growth Strategist & Fractional CMO
Forbes Top 20 Growth Hacker · TEDx Speaker · 716 Academic Citations · Ex-Microsoft · CMO at FirstWave (ASX:FCT) · Forbes Communications Council